Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria

被引:11
|
作者
Zimmerman, Tahl [1 ]
Carlos Lacal, Juan [2 ]
Ibrahim, Salam A. [1 ]
机构
[1] North Carolina Agr & Tech State Univ, Food & Nutr Sci Program, Food Microbiol & Biotechnol Lab, Greensboro, NC 27401 USA
[2] Hosp Univ Fuenlabrada, Dept Oncol, Madrid, Spain
来源
FRONTIERS IN MICROBIOLOGY | 2019年 / 10卷
关键词
choline kinase; antimicobial; antibiotic; gram-positive; Streptococcus pneumoniae; STREPTOCOCCUS-PNEUMONIAE; THERAPEUTIC TARGET; LIPOTEICHOIC ACID; BINDING-PROTEINS; CELL-WALL; ALPHA; PHOSPHORYLCHOLINE; INHIBITION; EXPRESSION; RSM-932A;
D O I
10.3389/fmicb.2019.02146
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Both nosocomial pathogens, such as Streptococcus pneumoniae and Haemophilus influenzae and food-borne pathogens, such as Bacillus cereus and Clostridium perfringens are known to be detrimental to human and animal health. The effectiveness of currently used treatments for these pathogens becomes limited as resistant strains emerge. Therefore, new methods for eliminating bacterial pathogens must be developed continuously. This includes establishing novel targets to which drug discovery efforts could be focused. A promising method for discovering new drug targets in prokaryotes is to take advantage of the information available regarding the enzymatic pathways that have been established as drug targets in eukaryotic systems and explore the analogous pathways found in bacterial systems. This is an efficient strategy because the same inhibitors developed at considerable expense to block these pathways in eukaryotic systems could also be employed in prokaryotes. Drugs that are used to prevent diseases involving eukaryotic cells could be repurposed as antibiotics and antimicrobials for the control of bacteria pathogens. This strategy could be pursued whenever the primary and tertiary structures of a target are are conserved between eukaryotic and prokaryotes. A possible novel target fitting these parameters is choline kinase (ChoK), whose active site sequences are conserved (Figure 1) and whose tertiary structure (Figure 2) is maintained. Here, we describe why ChoK is a putative drug target by describing its role in the growth and pathogenesis of Gram-positive bacteria S. pneumoniae and the Gram-negative bacteria H. influenzae. Using S. pneumoniae as a model, we also present promising preliminary information that repurposing of drugs known to inhibit the human isoform of ChoK (hChoK), is a promising strategy for blocking the growth of S. pneumoniae cells and inhibiting the activity of the S. pneumoniae isoform of ChoK (sChok), with downstream physiological effects on the cell wall.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Structural basis for the allosteric inhibition of UMP kinase from Gram-positive bacteria, a promising antibacterial target
    Walter, Patrick
    Mechaly, Ariel
    Bous, Julien
    Haouz, Ahmed
    England, Patrick
    Lai-Kee-Him, Josephine
    Ancelin, Aurelie
    Hoos, Sylviane
    Baron, Bruno
    Trapani, Stefano
    Bron, Patrick
    Labesse, Gilles
    Munier-Lehmann, Helene
    FEBS JOURNAL, 2022, 289 (16) : 4869 - 4887
  • [2] GRAM-POSITIVE BACTERIA AS ADJUVANTS
    HAHN, H
    IMMUNITAT UND INFEKTION, 1978, 6 (03): : 123 - 126
  • [3] Hyaluronidases of Gram-positive bacteria
    Hynes, WL
    Walton, SL
    FEMS MICROBIOLOGY LETTERS, 2000, 183 (02) : 201 - 207
  • [4] LIPOPROTEINS OF GRAM-POSITIVE BACTERIA
    SUTCLIFFE, IC
    RUSSELL, RRB
    JOURNAL OF BACTERIOLOGY, 1995, 177 (05) : 1123 - 1128
  • [5] Conjugation in Gram-Positive Bacteria
    Goessweiner-Mohr, Nikolaus
    Arends, Karsten
    Keller, Walter
    Grohmann, Elisabeth
    MICROBIOLOGY SPECTRUM, 2014, 2 (04):
  • [6] BACTERIOCINS OF GRAM-POSITIVE BACTERIA
    TAGG, JR
    DAJANI, AS
    WANNAMAKER, LW
    BACTERIOLOGICAL REVIEWS, 1976, 40 (03) : 722 - 756
  • [7] BACTERIOCINS OF GRAM-POSITIVE BACTERIA
    JACK, RW
    TAGG, JR
    RAY, B
    MICROBIOLOGICAL REVIEWS, 1995, 59 (02) : 171 - 200
  • [8] Integrons in Gram-positive bacteria
    Labiszak, Bartosz
    Koczura, Ryszard
    POSTEPY MIKROBIOLOGII, 2016, 55 (04): : 398 - 403
  • [9] Systematic analysis of drug combinations against Gram-positive bacteria
    Elisabetta Cacace
    Vladislav Kim
    Vallo Varik
    Michael Knopp
    Manuela Tietgen
    Amber Brauer-Nikonow
    Kemal Inecik
    André Mateus
    Alessio Milanese
    Marita Torrissen Mårli
    Karin Mitosch
    Joel Selkrig
    Ana Rita Brochado
    Oscar P. Kuipers
    Morten Kjos
    Georg Zeller
    Mikhail M. Savitski
    Stephan Göttig
    Wolfgang Huber
    Athanasios Typas
    Nature Microbiology, 2023, 8 : 2196 - 2212
  • [10] Efflux-mediated drug resistance in Gram-positive bacteria
    Markham, PN
    Neyfakh, AA
    CURRENT OPINION IN MICROBIOLOGY, 2001, 4 (05) : 509 - 514